ACSL4 and nasopharyngeal carcinoma: Subsequently, IP experiments showed that overexpression of SIRT3 inhibited the acetylation and protein expression of ACSL4 (Fig. 4E), while inhibition of SIRT3 with 3-TYP significantly enhanced the acetylation and protein expression of ACSL4 in NPC cells (Fig. 4F).